Drawing for CYTIVA

USPTO serial 88985331

CYTIVA

Reviewed by CopyMark Law Group

Reg. 7310679Status 700Registered
Filing date
Status date
Registration date
Feb 20, 2024
Examiner
LAW, CHRISTOPHER M
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with CYTIVA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Dyan House

Dyan House Baker & McKenzie LLP1900 N. Pearl Street, Suite 1500Dallas, TX 75201United States

Goods and services

ClassDescriptionStatusFirst use
007Filters made of fibers and membranes being part of industrial chromatography machinesACTIVEApr 1, 2020
009Downloadable computer software, namely, software for optimization, obtaining performance data, maintenance, remote diagnostics and troubleshooting, connectivity, calibration qualification, trade-ins, information about spare parts and kits, all for life science and bioprocess equipment; downloadable computer software for big data analyticsACTIVEDec 17, 2021
010Medical equipment comprising disposable sets of interconnected medical containers and interconnectable medical containers and fittings therefor, the disposable sets constituting accessories for use with apparatus for collecting, processing and storing blood, biological and cellular products for medical purposesACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 5, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 5, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 5, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 5, 2025CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Nov 5, 2025COARTEAS CHANGE OF OWNER ADDRESS RECEIVED
Feb 20, 2024NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED
Feb 20, 2024R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 19, 2024SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Jan 18, 2024CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Dec 6, 2023SUPCSTATEMENT OF USE PROCESSING COMPLETE
Dec 6, 2023DPCCDIVISIONAL PROCESSING COMPLETE
Nov 30, 2023IUAFUSE AMENDMENT FILED
Nov 30, 2023DRRRDIVISIONAL REQUEST RECEIVED
Nov 30, 2023ERTDTEAS REQUEST TO DIVIDE RECEIVED
Nov 30, 2023EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Jun 28, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 28, 2023NOACCORRECTED NOA E-MAILED
Jun 27, 2023EX2GSOU EXTENSION 2 GRANTED
Jun 27, 2023DPCCDIVISIONAL PROCESSING COMPLETE
Jun 20, 2023AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL
May 31, 2023EXT2SOU EXTENSION 2 FILED
May 31, 2023DRRRDIVISIONAL REQUEST RECEIVED
May 31, 2023ERTDTEAS REQUEST TO DIVIDE RECEIVED
May 31, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 1, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 29, 2022EX1GSOU EXTENSION 1 GRANTED
Nov 29, 2022EXT1SOU EXTENSION 1 FILED
Nov 29, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 31, 2022NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Apr 5, 2022NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 5, 2022PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 16, 2022NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 3, 2022CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Mar 3, 2022XAECEXAMINER'S AMENDMENT ENTERED
Mar 3, 2022GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 3, 2022GNEAEXAMINERS AMENDMENT E-MAILED
Mar 3, 2022CNEAEXAMINERS AMENDMENT -WRITTEN
Feb 5, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Feb 4, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 4, 2022ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED
Sep 8, 2021GNFNNOTIFICATION OF FINAL REFUSAL EMAILED
Sep 8, 2021GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Sep 8, 2021CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jul 20, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Jul 20, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 20, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 10, 2021GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 10, 2021GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 10, 2021CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 4, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Feb 3, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 3, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 5, 2021CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jan 5, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 5, 2021COARTEAS CHANGE OF OWNER ADDRESS RECEIVED
Jan 4, 2021CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jan 4, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 4, 2021COARTEAS CHANGE OF OWNER ADDRESS RECEIVED
Aug 3, 2020GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 3, 2020GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 3, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 27, 2020DOCKASSIGNED TO EXAMINER
May 14, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 5, 2020NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance